Another Contract Win...$11.1 + million in just 2 weeksAs I said in a post one or two days ago, we are going to be seeing a steady string of these Middle East contracts.
COV won 14 tenders in 2015, pilot tests more or less which we are now seeing being converted to solid contracts.
This contract award of a minimum of $3.5 million is massively significant for Covalon in Saudi Arabia and further strengthens Covalon as a major player in the Middle East.
Covalon fully expect to leverage the minimum commitment of $3.5 million into additional IV Clear revenue in Saudi Arabia. The win validates Covalon’s antimicrobial technology and will help us secure other contracts in the region and world-wide.
Those who remain non believers that they will build Covalon into a $1 billion company over the next 4 years outa rethink their strategy and hop aboard.
I am a strong believer that it will be delivered..